02220nas a2200241   4500008003900000245011400039210006900153260000800222300000600230490000700236520157100243100001201814700001301826700001101839700001201850700001201862700001101874700001101885700001201896700001301908700001201921856004501933       2021                          d00aMultiorgan Transplant From a Donor With Solid Renal Masses: An Initial Experience and Clinical Considerations0 aMultiorgan Transplant From a Donor With Solid Renal Masses An In  cOct  a30 v533 aBackground: Patients with early-stage renal cell carcinoma (RCC) are considered to be eligible donors. Although preliminary experience in using kidneys of specific pathologic types, mainly those with small renal masses (SRMs), have been established, multiorgan utilization of the same donor with SRMs is limited.

Methods: One deceased donor whose left-side kidney was diagnosed with Fuhrman grade I RCC was included. The tumor mass in the kidney was removed through partial nephrectomy according to the gold standard. Then, 3 transplant surgeries were performed, in which 1 recipient accepted kidney transplant after tumor exeresis, 1 simultaneous heart-kidney (the contralateral one) transplant, and 1 liver transplant. Recipients were followed up according to our standard protocol for renal cancers. (All allografts were allocated in compliance with the Declaration of Helsinki and the Declaration of Istanbul.) RESULTS: After 32 months, no radiographic findings showed any morphologic changes of the lesion, and all patients were in good condition, with neither tumor recurrence nor allograft rejection or infection. No complaints such as pain, oliguria, dyspnea, nausea, or fatigue were recorded.

Conclusions: To the best of knowledge, this initial work takes the lead in elaborating the organ utilization of multiorgan donors with SRMs. We hope the experience will provide support for cross discussion concerned with multiorgan transplant from tumor-affected donors in clinical practices, further expand the donor pool and address the donor shortage problem.1 aYang, F1 aJiang, H1 aGao, X1 aChen, H1 aZhao, W1 aZhu, Y1 aHan, L1 aZeng, L1 aZhang, L1 aChen, R  uhttps://notifylibrary.org/reference/4976